Signal active
Investment Firm
Overview
Cathay Capital is a leading international private equity firm active in cross-border investment. It supports the international expansion of middle-market companies in North America, China and Europe. Its team of 60 professionals based in New York, Shanghai, Beijing, Paris, Munich, and Silicon Valley leverages Cathay's business model and platform to create value for companies. With more than $1.5 billion in assets under management, Cathay Capital has completed buyouts and growth capital investments in 59 platform companies across three continents.
Highlights
2006
Financial Services
101-250
118
58
21
Early Stage Venture, Late Stage Venture, Seed, Private Equity
Private Equity Firm, Venture Capital
Location
Europe
Contact Information
Social
Profile Resume
Cathay Capital, established in 2006 and headquartered in Europe., specializes in Early Stage Venture, Late Stage Venture, Seed, Private Equity investments across Electronics, Manufacturing, Electrical Distribution, Financial Services, Venture Capital, Innovation Management, Life Science, Asset Management, Health Care, Pharmaceutical. The organization boasts a portfolio of 118 investments, with an average round size of $87.3M and 21 successful exits. Their recent investments include Amplitude, Auriga Partners, Mérieux Equity Partners, CDC Enterprises, Origene Technologies. The highest investment round they participated in was $486.7B. Among their most notable exits are Amplitude and Auriga Partners. Explore their portfolio in detail, see who is connected to them, and find their contact information on our platform.
Investment portfolio
118
1
58
21
Investments
118
Annouced Date | Organization Name | Industry | Money Raised |
---|---|---|---|
Jan 03, 2024 | Qiangua Technology | Automotive | 14.1M |
Jan 08, 2024 | Huiying Medical | Health Care | 14.1M |
Jan 29, 2024 | Mogic AI | Advertising Platforms | 15.0M |
Feb 21, 2024 | Bio-Link | Biotechnology | null |
Exits
21
Funding Timeline
118
0
11
Funding Rounds
118
Cathay Capital has raised 118 rounds. Their latest funding was raised on Feb 21, 2024 from a Series A - Bio-Link round.
Annouced Date | Transaction Name | Number of Investors | Money Raised | Lead Investor |
---|---|---|---|---|
Jan 03, 2024 | Seed Round - Qiangua Technology | - | 14.1M | - |
Jan 08, 2024 | Series B - Huiying Medical | - | 14.1M | - |
Jan 29, 2024 | Series A - Mogic AI | - | 15.0M | - |
Feb 21, 2024 | Series A - Bio-Link | - | 0 | - |
Investors
0
There is no funding round available on this profile
Fund raised
2
Susa Ventures has raised a total of $590M across 6 funds, their latest being Susa Ventures Opportunities II. This fund was announced on Aug 30, 2021 and raised a total of $250M.
Annouced Date | Fund Name | Money Raised |
---|---|---|
May 10, 2013 | OTPPLESS | 1.0M |
May 11, 2013 | OTPPLESS | 1.0M |
Invest in industries
Recent Activity
There is no recent news or activity for this profile.